Full View

miR-155 promotes FLT3-ITD–induced myeloproliferative disease through inhibition of the interferon response

JA Wallace, DA Kagele, AM Eiring… - Blood, The Journal …, 2017 - ashpublications.org
FLT3-ITD+ acute myeloid leukemia (AML) accounts for∼ 25% of all AML cases and is a
subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically …
被引用次数：66 相关文章
[HTML] nih.gov

[HTML][HTML] miR-155 promotes FLT3-ITD–induced myeloproliferative disease through inhibition of the interferon response

JA Wallace, DA Kagele, AM Eiring, CN Kim, R Hu… - Blood, 2017 - ncbi.nlm.nih.gov
FLT3-ITD+ acute myeloid leukemia (AML) accounts for∼ 25% of all AML cases and is a
subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically …

miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response

JA Wallace, DA Kagele, AM Eiring, CN Kim, R Hu… - …, 2017 - pubmed.ncbi.nlm.nih.gov
FLT3-ITD+ acute myeloid leukemia (AML) accounts for∼ 25% of all AML cases and is a
subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically …

MIR-155 PROMOTES FLT3-ITD-INDUCED MYELOPROLIFERATIVE DISEASE THROUGH INHIBITION OF THE INTERFERON RESPONSE

JA Wallace, DA Kagele, AM Eiring… - THE ROLE OF …, 2019 - search.proquest.com
FLT3-ITD+ acute myeloid leukemia (AML) accounts for∼ 25% of all AML cases and is a
subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically …
[PDF] core.ac.uk

[PDF][PDF] MIR-155 PROMOTES FLT3-ITD-INDUCED MYELOPROLIFERATIVE DISEASE THROUGH INHIBITION OF THE INTERFERON RESPONSE

JA Wallace, DA Kagele, AM Eiring, CN Kim… - STATEMENT OF …, 2018 - core.ac.uk
FLT3-ITD+ acute myeloid leukemia (AML) accounts for∼ 25% of all AML cases and is a
subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically …
[HTML] sciencedirect.com

[HTML][HTML] miR-155 promotes FLT3-ITD–induced myeloproliferative disease through inhibition of the interferon response

JA Wallace, DA Kagele, AM Eiring, CN Kim, R Hu… - Blood, 2017 - Elsevier
FLT3-ITD+ acute myeloid leukemia (AML) accounts for∼ 25% of all AML cases and is a
subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically …

miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response.

JA Wallace, DA Kagele, AM Eiring, CN Kim, R Hu… - Blood, 2017 - europepmc.org
FLT3-ITD+ acute myeloid leukemia (AML) accounts for~ 25% of all AML cases and is a
subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically …

miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response.

JA Wallace, DA Kagele, AM Eiring, CN Kim, R Hu… - Blood, 2017 - escholarship.org
FLT3-ITD+ acute myeloid leukemia (AML) accounts for∼ 25% of all AML cases and is a
subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically …

MIR-155 PROMOTES FLT3-ITD-INDUCED MYELOPROLIFERATIVE DISEASE THROUGH INHIBITION OF THE INTERFERON RESPONSE

JA Wallace, DA Kagele, AM Eiring… - THE ROLE OF …, 2019 - search.proquest.com
FLT3-ITD+ acute myeloid leukemia (AML) accounts for∼ 25% of all AML cases and is a
subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically …

miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response.

JA Wallace, DA Kagele, AM Eiring, CN Kim, R Hu… - Blood, 2017 - europepmc.org
FLT3-ITD+ acute myeloid leukemia (AML) accounts for~ 25% of all AML cases and is a
subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically …